News and Events | Spark Biomedical

September 12, 2024

Press Releases

Spark Biomedical Awarded National Institute on Drug Abuse Funding to Develop AI Algorithm for Opioid Withdrawal and Cravings Detection

This is some text inside of a div block.

Spark Biomedical is joined by the Battelle Memorial Institute and Hazelden Betty Ford Foundation to begin pioneering an AI-powered, wearable, closed-loop neurostimulation system to improve opioid withdrawal treatment retention and reduce relapse and overdose rates.

September 5, 2024

Press Releases

Spark Biomedical Introduces Sparrow Link: A Revolutionary Research Platform for Non-Invasive Neurostimulation

This is some text inside of a div block.

Spark Biomedical unveils the Sparrow® Link Research Platform designed to enable research teams to customize the transcutaneous auricular neurostimulation tAN power of the FDA-cleared Sparrow Ascent.

August 28, 2024

Press Releases

Spark Biomedical Has Been Issued New CMS Codes for Transcutaneous Auricular Neurostimulation (tAN® ) Therapy via Sparrow Ascent

This is some text inside of a div block.

The Centers for Medicare and Medicaid Services codes will help increase accessibility to wearable bioelectric medicine for opioid withdrawal.

April 22, 2024

Awards

EY Entrepreneur Of The Year® 2024 Southwest Award Finalist

This is some text inside of a div block.

Entrepreneur of the Year celebrates ambitious entrepreneurs who are shaping the future.

October 16, 2023

Media Coverage

Pathway to Cures Announces Venture Investment in Five Liters

This is some text inside of a div block.

Pathway to Cures (P2C) announced today its investment of $500,000 in Five Liters, a subsidiary of Spark Biomedical, to develop therapies for treating inheritable blood and bleeding disorders. Pathway to Cures, an affiliate of the National Bleeding Disorders Foundation, is a venture philanthropy fund focused on early-stage companies developing cures, therapies, or enabling technologies in support of the inheritable blood and bleeding disorders community.

August 29, 2023

Press Releases

Spark Biomedical Awarded $1.15M Department of Defense Phase II STTR Grant

This is some text inside of a div block.

The partnership focuses on testing wearable neurostimulation to prevent and treat acute stress reaction in the military.

August 8, 2023

Press Releases

Spark Biomedical Launches Telehealth Services for Sparrow Ascent, Improving Patient Access to Opioid Withdrawal Treatment

This is some text inside of a div block.

Spark Biomedical Inc., a U.S. leader in wearable neurostimulation solutions, is proud to announce the launch of telehealth services for their recently FDA-cleared product, Sparrow Ascent.

July 11, 2023

Press Releases

Spark Biomedical’s second-generation device, Sparrow® Ascent, Receives FDA Clearance for Opioid Withdrawal Relief in Adults

This is some text inside of a div block.

This FDA-cleared wearable neuromodulation system offers game-changing access for patients to start the road to recovery without interruptions to daily living

January 24, 2023

Media Coverage

WBAL TV Sparrow Therapy Coverage

This is some text inside of a div block.

The Hartford County Maryland Health Department is making the path to Opioid Use Disorder (OUD) recovery more attainable for local patients. The first step, providing patients access to the Sparrow Therapy System to overcome withdrawal symptoms.

January 19, 2023

Media Coverage

WCIV News Covers tANdem Clinical Trial

This is some text inside of a div block.

Ending opioid addiction in the Lowcountry is the goal of the Medical University of South Carolina staff as they get ready to launch a multi-year clinical trial to test a new device aimed at helping patients with opioid withdrawals.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

News & Events

News

Spark Biomedical Awarded National Institute on Drug Abuse Funding to Develop AI Algorithm for Opioid Withdrawal and Cravings Detection

Spark Biomedical Introduces Sparrow Link: A Revolutionary Research Platform for Non-Invasive Neurostimulation

Spark Biomedical Has Been Issued New CMS Codes for Transcutaneous Auricular Neurostimulation (tAN® ) Therapy via Sparrow Ascent

EY Entrepreneur Of The Year® 2024 Southwest Award Finalist

Pathway to Cures Announces Venture Investment in Five Liters

Spark Biomedical Awarded $1.15M Department of Defense Phase II STTR Grant

Spark Biomedical Launches Telehealth Services for Sparrow Ascent, Improving Patient Access to Opioid Withdrawal Treatment

Spark Biomedical’s second-generation device, Sparrow® Ascent, Receives FDA Clearance for Opioid Withdrawal Relief in Adults

WBAL TV Sparrow Therapy Coverage

WCIV News Covers tANdem Clinical Trial

Media Inquiries